SENS / Senseonics shares jump 6.7% on new insurance coverage for continuous glucose monitor

Senseonics Holdings (SENS) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 more_horizontal

Senseonics Holdings, Inc. (NYSE:SENS ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Philip Taylor - IR Tim Goodnow more_horizontal

If you're looking to buy penny stocks right now, you've got your work cut out for you. The massive volatility in the stock market today is unlike what more_horizontal

Shares of medical technology company Senseonics Holdings Inc. SENS, -0.52% gained 6.7% premarket on Friday after the company announced that UnitedHeal more_horizontal

Senseonics Holdings, Inc. (NYSE:SENS ) Q2 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Philip Taylor - IR Tim Goodnow - P more_horizontal

Senseonics Holdings, Inc. (NYSE:SENS ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Philip Taylor – Investor Re more_horizontal

The partnership between Senseonics Holdings and Elevance Health (formerly Anthem) is expected to increase coverage to Senseonics' implantable CGM syst more_horizontal

Senseonics (NYSEAMERICAN: SENS ) stock jumped by over 50% after it announced its Eversense implantable glucose monitor was approved for coverage by El more_horizontal